| hindbrain tangential cell migration | GO:0021934 | 2 | 0.660 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.577 | |
| neural crest cell migration involved in autonomic nervous system development | GO:1901166 | 5 | 0.508 | |
| regulation of glial cell differentiation | GO:0045685 | 41 | 0.365 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.364 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.344 | |
| male gamete generation | GO:0048232 | 285 | 0.333 | |
| regulation of synaptic growth at neuromuscular junction | GO:0008582 | 4 | 0.320 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.255 | |
| organophosphate biosynthetic process | GO:0090407 | 122 | 0.251 | |
| rhombomere morphogenesis | GO:0021593 | 2 | 0.235 | |
| sensory perception | GO:0007600 | 245 | 0.234 | |
| g protein coupled receptor signaling pathway | GO:0007186 | 243 | 0.222 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.220 | |
| regulation of astrocyte differentiation | GO:0048710 | 20 | 0.219 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.216 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.212 | |
| myotube differentiation | GO:0014902 | 105 | 0.202 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.197 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.197 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.193 | |
| cardiac muscle cell differentiation | GO:0055007 | 69 | 0.190 | |
| cellular homeostasis | GO:0019725 | 240 | 0.188 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.185 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.178 | |
| developmental pigmentation | GO:0048066 | 40 | 0.177 | |
| cyclic purine nucleotide metabolic process | GO:0052652 | 43 | 0.176 | |
| regulation of cell substrate adhesion | GO:0010810 | 73 | 0.176 | |
| nucleoside phosphate biosynthetic process | GO:1901293 | 79 | 0.175 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.171 | |
| regulation of hippo signaling | GO:0035330 | 1 | 0.171 | |
| ribonucleotide biosynthetic process | GO:0009260 | 59 | 0.171 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.168 | |
| regulation of gtp catabolic process | GO:0033124 | 113 | 0.163 | |
| branch elongation involved in ureteric bud branching | GO:0060681 | 3 | 0.162 | |
| ribose phosphate biosynthetic process | GO:0046390 | 59 | 0.161 | |
| nucleotide biosynthetic process | GO:0009165 | 78 | 0.158 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.157 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.156 | |
| ascending aorta morphogenesis | GO:0035910 | 3 | 0.155 | |
| gliogenesis | GO:0042063 | 141 | 0.153 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.152 | |
| regulation of gliogenesis | GO:0014013 | 50 | 0.152 | |
| oculomotor nerve morphogenesis | GO:0021622 | 2 | 0.151 | |
| rac protein signal transduction | GO:0016601 | 13 | 0.150 | |
| telencephalon development | GO:0021537 | 186 | 0.149 | |
| closure of optic fissure | GO:0061386 | 2 | 0.149 | |
| positive regulation of secondary heart field cardioblast proliferation | GO:0072513 | 4 | 0.148 | |
| membrane organization | GO:0061024 | 245 | 0.148 | |
| glucose homeostasis | GO:0042593 | 128 | 0.143 | |
| regulation of apoptotic process involved in outflow tract morphogenesis | GO:1902256 | 2 | 0.142 | |
| purine nucleotide biosynthetic process | GO:0006164 | 65 | 0.133 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.128 | |
| rhombomere development | GO:0021546 | 8 | 0.127 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.126 | |
| negative regulation of glial cell differentiation | GO:0045686 | 21 | 0.124 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.121 | |
| actomyosin structure organization | GO:0031032 | 56 | 0.121 | |
| purine containing compound biosynthetic process | GO:0072522 | 70 | 0.120 | |
| metanephric capsule specification | GO:0072267 | 1 | 0.118 | |
| pyramidal neuron migration | GO:0021852 | 1 | 0.118 | |
| negative regulation of astrocyte differentiation | GO:0048712 | 10 | 0.117 | |
| cyclic nucleotide biosynthetic process | GO:0009190 | 44 | 0.114 | |
| endothelin receptor signaling pathway | GO:0086100 | 3 | 0.114 | |
| noradrenergic neuron differentiation | GO:0003357 | 6 | 0.113 | |
| sinoatrial node cell differentiation | GO:0060921 | 3 | 0.112 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.112 | |
| germ cell development | GO:0007281 | 185 | 0.111 | |
| regulation of neuron apoptotic process | GO:0043523 | 122 | 0.111 | |
| cellular response to lipid | GO:0071396 | 145 | 0.111 | |
| parasympathetic nervous system development | GO:0048486 | 19 | 0.111 | |
| negative regulation of glial cell proliferation | GO:0060253 | 4 | 0.109 | |
| midbrain hindbrain boundary morphogenesis | GO:0021555 | 4 | 0.108 | |
| positive regulation of epithelial cell proliferation | GO:0050679 | 68 | 0.107 | |
| positive regulation of cyclic nucleotide metabolic process | GO:0030801 | 24 | 0.107 | |
| columnar cuboidal epithelial cell differentiation | GO:0002065 | 82 | 0.106 | |
| regulation of cyclic nucleotide biosynthetic process | GO:0030802 | 31 | 0.106 | |
| biomineral tissue development | GO:0031214 | 64 | 0.105 | |
| endocrine system development | GO:0035270 | 98 | 0.105 | |
| regulation of nucleotide biosynthetic process | GO:0030808 | 34 | 0.104 | |
| spermatid differentiation | GO:0048515 | 115 | 0.103 | |
| aorta development | GO:0035904 | 23 | 0.102 | |
| cartilage development | GO:0051216 | 140 | 0.101 | |
| nodal signaling pathway involved in determination of lateral mesoderm left right asymmetry | GO:1900164 | 2 | 0.097 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.097 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.096 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.096 | |
| developmental maturation | GO:0021700 | 193 | 0.096 | |
| regulation of cysteine type endopeptidase activity involved in apoptotic process | GO:0043281 | 62 | 0.095 | |
| regulation of transcription involved in primary germ layer cell fate commitment | GO:0060796 | 2 | 0.094 | |
| carbon catabolite activation of transcription from rna polymerase ii promoter | GO:0000436 | 4 | 0.093 | |
| negative regulation of neuron death | GO:1901215 | 98 | 0.093 | |
| regionalization | GO:0003002 | 337 | 0.091 | |
| neuron maturation | GO:0042551 | 29 | 0.090 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.089 | |
| potassium ion homeostasis | GO:0055075 | 4 | 0.088 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.088 | |
| apoptotic process involved in outflow tract morphogenesis | GO:0003275 | 2 | 0.087 | |
| negative regulation of photoreceptor cell differentiation | GO:0046533 | 4 | 0.087 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.087 | |
| cation transport | GO:0006812 | 399 | 0.086 | |
| positive regulation of satellite cell activation involved in skeletal muscle regeneration | GO:0014718 | 2 | 0.086 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.085 | |
| regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis | GO:0072039 | 4 | 0.085 | |
| endocardial cushion to mesenchymal transition involved in heart valve formation | GO:0003199 | 4 | 0.085 | |
| camp biosynthetic process | GO:0006171 | 31 | 0.083 | |
| mesenchyme development | GO:0060485 | 152 | 0.083 | |
| muscle cell development | GO:0055001 | 133 | 0.082 | |
| regulation of stem cell differentiation | GO:2000736 | 50 | 0.081 | |
| divalent inorganic cation homeostasis | GO:0072507 | 138 | 0.081 | |
| regulation of camp biosynthetic process | GO:0030817 | 25 | 0.081 | |
| neural crest cell development | GO:0014032 | 48 | 0.081 | |
| negative regulation of neuron apoptotic process | GO:0043524 | 92 | 0.080 | |
| somitogenesis | GO:0001756 | 69 | 0.080 | |
| mapk cascade | GO:0000165 | 281 | 0.080 | |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.080 | |
| circadian behavior | GO:0048512 | 13 | 0.079 | |
| neural retina development | GO:0003407 | 41 | 0.079 | |
| astrocyte differentiation | GO:0048708 | 43 | 0.078 | |
| specification of organ position | GO:0010159 | 3 | 0.078 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.078 | |
| positive regulation of nucleotide metabolic process | GO:0045981 | 114 | 0.078 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.078 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.078 | |
| purine ribonucleotide biosynthetic process | GO:0009152 | 59 | 0.077 | |
| cell adhesion | GO:0007155 | 329 | 0.076 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.075 | |
| camp metabolic process | GO:0046058 | 40 | 0.074 | |
| lens development in camera type eye | GO:0002088 | 62 | 0.074 | |
| spermatogenesis | GO:0007283 | 284 | 0.074 | |
| negative regulation of skeletal muscle cell differentiation | GO:2001015 | 1 | 0.073 | |
| stem cell differentiation | GO:0048863 | 268 | 0.073 | |
| glial cell differentiation | GO:0010001 | 131 | 0.073 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.072 | |
| carbon catabolite repression of transcription from rna polymerase ii promoter | GO:0000437 | 1 | 0.072 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.071 | |
| regulation of camp metabolic process | GO:0030814 | 30 | 0.071 | |
| negative regulation of apoptotic process involved in outflow tract morphogenesis | GO:1902257 | 2 | 0.071 | |
| neuromuscular process controlling balance | GO:0050885 | 59 | 0.071 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.070 | |
| positive regulation of skeletal muscle tissue regeneration | GO:0043415 | 4 | 0.070 | |
| oligodendrocyte differentiation | GO:0048709 | 53 | 0.070 | |
| negative regulation of cell development | GO:0010721 | 169 | 0.070 | |
| response to light stimulus | GO:0009416 | 135 | 0.070 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.069 | |
| male gonad development | GO:0008584 | 88 | 0.069 | |
| male sex determination | GO:0030238 | 14 | 0.068 | |
| rhombomere 5 development | GO:0021571 | 4 | 0.068 | |
| positive regulation of transcription from rna polymerase ii promoter involved in myocardial precursor cell differentiation | GO:0003257 | 3 | 0.067 | |
| heart morphogenesis | GO:0003007 | 178 | 0.067 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.067 | |
| tube formation | GO:0035148 | 140 | 0.066 | |
| positive regulation of cytosolic calcium ion concentration involved in phospholipase c activating g protein coupled signaling pathway | GO:0051482 | 4 | 0.066 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.066 | |
| regulation of myoblast differentiation | GO:0045661 | 29 | 0.065 | |
| neural tube development | GO:0021915 | 160 | 0.065 | |
| erk1 and erk2 cascade | GO:0070371 | 77 | 0.064 | |
| gtp catabolic process | GO:0006184 | 143 | 0.064 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.064 | |
| ear development | GO:0043583 | 200 | 0.064 | |
| sinoatrial node cell development | GO:0060931 | 3 | 0.064 | |
| smoothened signaling pathway | GO:0007224 | 105 | 0.064 | |
| cyclic nucleotide metabolic process | GO:0009187 | 59 | 0.063 | |
| positive regulation of endothelial cell proliferation | GO:0001938 | 17 | 0.063 | |
| thymus development | GO:0048538 | 41 | 0.063 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.062 | |
| negative regulation of synapse assembly | GO:0051964 | 3 | 0.061 | |
| regulation of purine nucleotide biosynthetic process | GO:1900371 | 34 | 0.060 | |
| circadian rhythm | GO:0007623 | 114 | 0.060 | |
| vascular smooth muscle contraction | GO:0014829 | 5 | 0.060 | |
| axon target recognition | GO:0007412 | 4 | 0.060 | |
| cell maturation | GO:0048469 | 127 | 0.060 | |
| cerebral cortex development | GO:0021987 | 86 | 0.060 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.060 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.060 | |
| striated muscle cell development | GO:0055002 | 125 | 0.059 | |
| skeletal muscle cell differentiation | GO:0035914 | 66 | 0.059 | |
| positive regulation of purine nucleotide metabolic process | GO:1900544 | 114 | 0.058 | |
| cardiac cell fate specification | GO:0060912 | 2 | 0.058 | |
| regulation of neuron maturation | GO:0014041 | 5 | 0.058 | |
| development of primary male sexual characteristics | GO:0046546 | 88 | 0.058 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.058 | |
| neuron apoptotic process | GO:0051402 | 142 | 0.058 | |
| trochlear nerve development | GO:0021558 | 3 | 0.058 | |
| response to molecule of bacterial origin | GO:0002237 | 143 | 0.057 | |
| negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis | GO:0072040 | 4 | 0.057 | |
| mitral valve development | GO:0003174 | 4 | 0.057 | |
| blastocyst development | GO:0001824 | 80 | 0.057 | |
| respiratory system process | GO:0003016 | 25 | 0.057 | |
| response to oxygen levels | GO:0070482 | 62 | 0.056 | |
| muscle cell proliferation | GO:0033002 | 52 | 0.056 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.056 | |
| nodal signaling pathway involved in determination of left right asymmetry | GO:0038107 | 2 | 0.056 | |
| eye photoreceptor cell differentiation | GO:0001754 | 41 | 0.055 | |
| regulation of ph | GO:0006885 | 26 | 0.055 | |
| protein kinase c activating g protein coupled receptor signaling pathway | GO:0007205 | 4 | 0.054 | |
| myoblast migration | GO:0051451 | 8 | 0.054 | |
| inorganic cation transmembrane transport | GO:0098662 | 207 | 0.054 | |
| hindbrain development | GO:0030902 | 128 | 0.054 | |
| forebrain neuron development | GO:0021884 | 30 | 0.054 | |
| stress activated protein kinase signaling cascade | GO:0031098 | 81 | 0.054 | |
| regulation of transcription from rna polymerase iii promoter | GO:0006359 | 2 | 0.053 | |
| regulation of oligodendrocyte differentiation | GO:0048713 | 23 | 0.053 | |
| cardiac left ventricle formation | GO:0003218 | 1 | 0.053 | |
| positive regulation of transcription from rna polymerase ii promoter involved in heart development | GO:1901228 | 4 | 0.053 | |
| regulation of cell motility | GO:2000145 | 236 | 0.052 | |
| regulation of cyclic nucleotide metabolic process | GO:0030799 | 40 | 0.052 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.052 | |
| negative regulation of hydrolase activity | GO:0051346 | 71 | 0.052 | |
| muscle adaptation | GO:0043500 | 39 | 0.052 | |
| endodermal cell fate specification | GO:0001714 | 4 | 0.051 | |
| response to lipopolysaccharide | GO:0032496 | 128 | 0.051 | |
| pigment cell differentiation | GO:0050931 | 27 | 0.051 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.051 | |
| cell fate specification | GO:0001708 | 72 | 0.051 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.051 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.051 | |
| urea homeostasis | GO:0097274 | 2 | 0.050 | |
| positive regulation of erk1 and erk2 cascade | GO:0070374 | 47 | 0.050 | |
| positive regulation of cellular catabolic process | GO:0031331 | 148 | 0.050 | |
| mitral valve morphogenesis | GO:0003183 | 4 | 0.049 | |
| regulation of rac protein signal transduction | GO:0035020 | 19 | 0.049 | |
| stem cell development | GO:0048864 | 219 | 0.049 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.049 | |
| myotome development | GO:0061055 | 4 | 0.049 | |
| positive regulation of purine nucleotide biosynthetic process | GO:1900373 | 26 | 0.049 | |
| spermatid development | GO:0007286 | 108 | 0.049 | |
| myotube cell development | GO:0014904 | 60 | 0.048 | |
| artery smooth muscle contraction | GO:0014824 | 2 | 0.048 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.048 | |
| ductus arteriosus closure | GO:0097070 | 3 | 0.048 | |
| cellular component assembly involved in morphogenesis | GO:0010927 | 139 | 0.048 | |
| vascular wound healing | GO:0061042 | 3 | 0.048 | |
| negative regulation of gliogenesis | GO:0014014 | 23 | 0.048 | |
| ureteric bud morphogenesis | GO:0060675 | 62 | 0.048 | |
| ventricular cardiac muscle cell differentiation | GO:0055012 | 17 | 0.048 | |
| hormone secretion | GO:0046879 | 128 | 0.047 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.047 | |
| regulation of neural precursor cell proliferation | GO:2000177 | 70 | 0.047 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.047 | |
| regulation of purine nucleotide catabolic process | GO:0033121 | 122 | 0.047 | |
| guanosine containing compound metabolic process | GO:1901068 | 144 | 0.047 | |
| cardiac chamber morphogenesis | GO:0003206 | 93 | 0.047 | |
| fungiform papilla morphogenesis | GO:0061197 | 5 | 0.047 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.047 | |
| nephron tubule morphogenesis | GO:0072078 | 68 | 0.046 | |
| retinal rod cell differentiation | GO:0060221 | 2 | 0.046 | |
| carbohydrate homeostasis | GO:0033500 | 128 | 0.046 | |
| mesenchymal cell development | GO:0014031 | 93 | 0.046 | |
| regulation of system process | GO:0044057 | 200 | 0.046 | |
| ear morphogenesis | GO:0042471 | 118 | 0.046 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.046 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.046 | |
| nucleocytoplasmic transport | GO:0006913 | 139 | 0.046 | |
| smooth muscle tissue development | GO:0048745 | 22 | 0.046 | |
| renal capsule specification | GO:0072130 | 1 | 0.046 | |
| locomotory behavior | GO:0007626 | 195 | 0.046 | |
| stress activated mapk cascade | GO:0051403 | 80 | 0.045 | |
| chondrocyte differentiation | GO:0002062 | 72 | 0.045 | |
| protein localization to nucleus | GO:0034504 | 121 | 0.045 | |
| forebrain morphogenesis | GO:0048853 | 17 | 0.045 | |
| neural crest cell fate commitment | GO:0014034 | 1 | 0.045 | |
| epithelial cell development | GO:0002064 | 159 | 0.045 | |
| negative regulation of branching involved in ureteric bud morphogenesis | GO:0090191 | 4 | 0.045 | |
| regulation of cell migration | GO:0030334 | 219 | 0.044 | |
| optic vesicle morphogenesis | GO:0003404 | 2 | 0.044 | |
| posterior midgut development | GO:0007497 | 1 | 0.044 | |
| ventral spinal cord development | GO:0021517 | 48 | 0.044 | |
| regulation of skeletal muscle fiber development | GO:0048742 | 36 | 0.044 | |
| g0 to g1 transition | GO:0045023 | 3 | 0.044 | |
| forebrain development | GO:0030900 | 302 | 0.043 | |
| positive regulation of defense response | GO:0031349 | 124 | 0.043 | |
| actin filament organization | GO:0007015 | 113 | 0.043 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.043 | |
| oculomotor nerve development | GO:0021557 | 4 | 0.043 | |
| otolith morphogenesis | GO:0032474 | 3 | 0.043 | |
| embryonic epithelial tube formation | GO:0001838 | 130 | 0.043 | |
| negative regulation of neuron differentiation | GO:0045665 | 101 | 0.043 | |
| neural precursor cell proliferation | GO:0061351 | 121 | 0.042 | |
| sequestering of calcium ion | GO:0051208 | 18 | 0.042 | |
| positive regulation of transcription elongation from rna polymerase ii promoter | GO:0032968 | 2 | 0.042 | |
| ossification | GO:0001503 | 216 | 0.042 | |
| regulation of mesenchymal cell proliferation involved in ureter development | GO:0072199 | 3 | 0.042 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.042 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.041 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.041 | |
| cranial ganglion development | GO:0061550 | 5 | 0.041 | |
| myelination in peripheral nervous system | GO:0022011 | 19 | 0.041 | |
| metanephros development | GO:0001656 | 79 | 0.041 | |
| positive regulation of muscle hypertrophy | GO:0014742 | 2 | 0.041 | |
| respiratory system development | GO:0060541 | 190 | 0.041 | |
| sarcomere organization | GO:0045214 | 24 | 0.040 | |
| plasma membrane organization | GO:0007009 | 90 | 0.040 | |
| extrinsic apoptotic signaling pathway in absence of ligand | GO:0097192 | 55 | 0.040 | |
| regulation of cysteine type endopeptidase activity | GO:2000116 | 65 | 0.040 | |
| mesenchymal cell proliferation involved in ureter development | GO:0072198 | 4 | 0.040 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.040 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.040 | |
| cardiac muscle tissue development | GO:0048738 | 130 | 0.039 | |
| glomerular mesangial cell development | GO:0072144 | 3 | 0.039 | |
| neuroblast proliferation | GO:0007405 | 49 | 0.039 | |
| connective tissue development | GO:0061448 | 179 | 0.039 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.039 | |
| mesenchymal cell differentiation | GO:0048762 | 107 | 0.039 | |
| response to hypoxia | GO:0001666 | 58 | 0.039 | |
| skeletal system development | GO:0001501 | 356 | 0.039 | |
| establishment of protein localization to organelle | GO:0072594 | 118 | 0.039 | |
| rhombomere 3 development | GO:0021569 | 4 | 0.039 | |
| response to iron ion | GO:0010039 | 4 | 0.039 | |
| syncytium formation | GO:0006949 | 43 | 0.038 | |
| positive regulation of cell activation | GO:0050867 | 158 | 0.038 | |
| t cell activation | GO:0042110 | 289 | 0.038 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.038 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.038 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.037 | |
| mesoderm development | GO:0007498 | 100 | 0.037 | |
| regulation of protein complex assembly | GO:0043254 | 83 | 0.037 | |
| melanocyte differentiation | GO:0030318 | 25 | 0.037 | |
| immune effector process | GO:0002252 | 321 | 0.037 | |
| atrial septum primum morphogenesis | GO:0003289 | 3 | 0.037 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.037 | |
| cell chemotaxis | GO:0060326 | 81 | 0.037 | |
| positive regulation of odontogenesis | GO:0042482 | 4 | 0.037 | |
| regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090092 | 112 | 0.037 | |
| neuron projection extension | GO:1990138 | 64 | 0.037 | |
| regulation of muscle system process | GO:0090257 | 80 | 0.037 | |
| axial mesoderm formation | GO:0048320 | 3 | 0.037 | |
| copulation | GO:0007620 | 7 | 0.037 | |
| cell proliferation in external granule layer | GO:0021924 | 10 | 0.037 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.036 | |
| monovalent inorganic cation homeostasis | GO:0055067 | 33 | 0.036 | |
| inner ear morphogenesis | GO:0042472 | 101 | 0.036 | |
| respiratory gaseous exchange | GO:0007585 | 43 | 0.036 | |
| regulation of secretion | GO:0051046 | 274 | 0.036 | |
| neural crest cell differentiation | GO:0014033 | 54 | 0.036 | |
| neutrophil chemotaxis | GO:0030593 | 36 | 0.036 | |
| embryonic skeletal system development | GO:0048706 | 120 | 0.036 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.036 | |
| muscle system process | GO:0003012 | 141 | 0.036 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.036 | |
| thyroid stimulating hormone secreting cell differentiation | GO:0060129 | 4 | 0.036 | |
| negative regulation of gastrulation | GO:2000542 | 3 | 0.036 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.036 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.035 | |
| adaptive immune response | GO:0002250 | 155 | 0.035 | |
| soft palate development | GO:0060023 | 2 | 0.035 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.035 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.035 | |
| muscle contraction | GO:0006936 | 101 | 0.035 | |
| cellular response to biotic stimulus | GO:0071216 | 92 | 0.035 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 104 | 0.035 | |
| pallium development | GO:0021543 | 120 | 0.034 | |
| pancreas morphogenesis | GO:0061113 | 3 | 0.034 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.034 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.034 | |
| regulation of calcium ion transport | GO:0051924 | 69 | 0.034 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.034 | |
| cellular response to external stimulus | GO:0071496 | 88 | 0.034 | |
| neural tube formation | GO:0001841 | 108 | 0.034 | |
| developmental growth involved in morphogenesis | GO:0060560 | 138 | 0.034 | |
| retinal bipolar neuron differentiation | GO:0060040 | 5 | 0.034 | |
| his purkinje system cell differentiation | GO:0060932 | 2 | 0.034 | |
| regulation of tongue muscle cell differentiation | GO:2001035 | 2 | 0.034 | |
| forebrain neuron differentiation | GO:0021879 | 52 | 0.034 | |
| sensory perception of pain | GO:0019233 | 47 | 0.034 | |
| cartilage condensation | GO:0001502 | 18 | 0.033 | |
| protein processing | GO:0016485 | 163 | 0.033 | |
| chromatin assembly | GO:0031497 | 13 | 0.033 | |
| cell cell signaling involved in cell fate commitment | GO:0045168 | 35 | 0.033 | |
| endocrine pancreas development | GO:0031018 | 29 | 0.033 | |
| dna metabolic process | GO:0006259 | 303 | 0.033 | |
| astrocyte development | GO:0014002 | 12 | 0.033 | |
| chromatin organization | GO:0006325 | 206 | 0.033 | |
| ascending aorta development | GO:0035905 | 3 | 0.033 | |
| myelination | GO:0042552 | 74 | 0.033 | |
| regulation of metal ion transport | GO:0010959 | 106 | 0.033 | |
| tricuspid valve development | GO:0003175 | 3 | 0.033 | |
| mammary gland morphogenesis | GO:0060443 | 54 | 0.033 | |
| protein targeting | GO:0006605 | 143 | 0.033 | |
| negative regulation of nervous system development | GO:0051961 | 156 | 0.033 | |
| cell division | GO:0051301 | 120 | 0.032 | |
| insulin secretion | GO:0030073 | 89 | 0.032 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.032 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.032 | |
| regulation of neuron death | GO:1901214 | 134 | 0.032 | |
| locus ceruleus development | GO:0021703 | 1 | 0.032 | |
| positive regulation of branching involved in lung morphogenesis | GO:0061047 | 4 | 0.032 | |
| regulation of nucleotide catabolic process | GO:0030811 | 122 | 0.032 | |
| camera type eye development | GO:0043010 | 266 | 0.032 | |
| protein localization to organelle | GO:0033365 | 185 | 0.032 | |
| regulation of striated muscle cell differentiation | GO:0051153 | 81 | 0.032 | |
| histamine transport | GO:0051608 | 2 | 0.032 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.032 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.032 | |
| regulation of wound healing | GO:0061041 | 40 | 0.032 | |
| neuron death | GO:0070997 | 154 | 0.031 | |
| outflow tract morphogenesis | GO:0003151 | 53 | 0.031 | |
| heart field specification | GO:0003128 | 6 | 0.031 | |
| calcium ion homeostasis | GO:0055074 | 127 | 0.031 | |
| maternal process involved in parturition | GO:0060137 | 1 | 0.031 | |
| receptor recycling | GO:0001881 | 11 | 0.031 | |
| regulation of actin cytoskeleton organization | GO:0032956 | 84 | 0.031 | |
| myofibril assembly | GO:0030239 | 34 | 0.031 | |
| cardiac muscle cell development | GO:0055013 | 39 | 0.031 | |
| regulation of blood circulation | GO:1903522 | 93 | 0.031 | |
| tangential migration from the subventricular zone to the olfactory bulb | GO:0022028 | 5 | 0.031 | |
| trigeminal ganglion development | GO:0061551 | 5 | 0.031 | |
| positive regulation of mesenchymal cell proliferation involved in ureter development | GO:2000729 | 3 | 0.031 | |
| ephrin receptor signaling pathway | GO:0048013 | 20 | 0.030 | |
| kidney development | GO:0001822 | 213 | 0.030 | |
| septum primum development | GO:0003284 | 4 | 0.030 | |
| regulation of cell cycle phase transition | GO:1901987 | 77 | 0.030 | |
| response to morphine | GO:0043278 | 9 | 0.029 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.029 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.029 | |
| adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002460 | 145 | 0.029 | |
| neuroepithelial cell differentiation | GO:0060563 | 37 | 0.029 | |
| regulation of cytoskeleton organization | GO:0051493 | 122 | 0.029 | |
| regulation of neuron projection development | GO:0010975 | 169 | 0.029 | |
| regulation of histone modification | GO:0031056 | 56 | 0.029 | |
| protein import into nucleus | GO:0006606 | 95 | 0.029 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.029 | |
| pigmentation | GO:0043473 | 71 | 0.029 | |
| otic placode formation | GO:0043049 | 1 | 0.029 | |
| protein import | GO:0017038 | 101 | 0.029 | |
| male sex differentiation | GO:0046661 | 109 | 0.028 | |
| neuromuscular process | GO:0050905 | 99 | 0.028 | |
| leukocyte migration | GO:0050900 | 124 | 0.028 | |
| organelle assembly | GO:0070925 | 177 | 0.028 | |
| protein modification by small protein conjugation | GO:0032446 | 187 | 0.028 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.028 | |
| myeloid leukocyte differentiation | GO:0002573 | 119 | 0.028 | |
| actin polymerization or depolymerization | GO:0008154 | 54 | 0.028 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.028 | |
| response to monosaccharide | GO:0034284 | 67 | 0.028 | |
| nose development | GO:0043584 | 12 | 0.028 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.028 | |
| embryonic heart tube development | GO:0035050 | 65 | 0.027 | |
| sequestering of metal ion | GO:0051238 | 19 | 0.027 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.027 | |
| regulation of branch elongation involved in ureteric bud branching | GO:0072095 | 3 | 0.027 | |
| forebrain generation of neurons | GO:0021872 | 63 | 0.027 | |
| carboxylic acid biosynthetic process | GO:0046394 | 86 | 0.027 | |
| guanosine containing compound catabolic process | GO:1901069 | 144 | 0.027 | |
| neuron fate specification | GO:0048665 | 30 | 0.027 | |
| pancreas development | GO:0031016 | 57 | 0.027 | |
| urogenital system development | GO:0001655 | 261 | 0.027 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.027 | |
| epithelial cell maturation involved in prostate gland development | GO:0060743 | 4 | 0.027 | |
| transmission of nerve impulse | GO:0019226 | 76 | 0.027 | |
| regulation of satellite cell proliferation | GO:0014842 | 5 | 0.027 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.026 | |
| signal transduction in absence of ligand | GO:0038034 | 55 | 0.026 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.026 | |
| pituitary gland development | GO:0021983 | 38 | 0.026 | |
| regulation of synapse assembly | GO:0051963 | 29 | 0.026 | |
| central nervous system neuron development | GO:0021954 | 67 | 0.026 | |
| cerebellar granule cell precursor proliferation | GO:0021930 | 10 | 0.026 | |
| microtubule cytoskeleton organization | GO:0000226 | 157 | 0.026 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.026 | |
| glomerular mesangial cell differentiation | GO:0072008 | 3 | 0.026 | |
| regulation of chondrocyte differentiation | GO:0032330 | 33 | 0.026 | |
| rhombomere formation | GO:0021594 | 1 | 0.026 | |
| neural tube closure | GO:0001843 | 90 | 0.026 | |
| protein polymerization | GO:0051258 | 57 | 0.026 | |
| endocardium development | GO:0003157 | 10 | 0.026 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.026 | |
| mesenchymal cell apoptotic process involved in nephron morphogenesis | GO:1901145 | 4 | 0.026 | |
| regulation of myotube differentiation | GO:0010830 | 62 | 0.026 | |
| corticotropin hormone secreting cell differentiation | GO:0060128 | 3 | 0.026 | |
| developmental cell growth | GO:0048588 | 84 | 0.025 | |
| regulation of endopeptidase activity | GO:0052548 | 89 | 0.025 | |
| positive regulation of cell cycle | GO:0045787 | 92 | 0.025 | |
| regulation of skeletal muscle cell differentiation | GO:2001014 | 11 | 0.025 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.025 | |
| skeletal muscle tissue regeneration | GO:0043403 | 20 | 0.025 | |
| sensory perception of mechanical stimulus | GO:0050954 | 107 | 0.025 | |
| spinal cord development | GO:0021510 | 81 | 0.025 | |
| carbon catabolite activation of transcription | GO:0045991 | 4 | 0.025 | |
| skin development | GO:0043588 | 220 | 0.025 | |
| regulation of mesonephros development | GO:0061217 | 24 | 0.025 | |
| positive regulation of chemotaxis | GO:0050921 | 38 | 0.025 | |
| positive regulation of immune effector process | GO:0002699 | 107 | 0.025 | |
| negative regulation of mesenchymal cell proliferation | GO:0072201 | 3 | 0.025 | |
| lateral inhibition | GO:0046331 | 1 | 0.025 | |
| facial nerve development | GO:0021561 | 11 | 0.025 | |
| renal capsule formation | GO:0072129 | 1 | 0.025 | |
| aorta morphogenesis | GO:0035909 | 22 | 0.025 | |
| renal tubule morphogenesis | GO:0061333 | 72 | 0.025 | |
| regulation of protein localization | GO:0032880 | 231 | 0.025 | |
| regulation of neurotransmitter levels | GO:0001505 | 87 | 0.025 | |
| cation homeostasis | GO:0055080 | 212 | 0.025 | |
| positive regulation of oligodendrocyte differentiation | GO:0048714 | 9 | 0.025 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.025 | |
